Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases

Journal of Inherited Metabolic Disease

Volumn 40, Issue 5, 2017, Pages 631-640

  Saffari, Afshin ^a   Kölker, Stefan ^a   Hoffmann, Georg F ^a   Ebrahimi Fakhari, Darius ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CASPASE 9 INHIBITOR; NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE; SIRTUIN; REACTIVE OXYGEN METABOLITE;

BRAIN MITOCHONDRION; CALCIUM HOMEOSTASIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXPERIMENTAL THERAPY; GAUCHER DISEASE; GLOBOID CELL LEUKODYSTROPHY; GM1 GANGLIOSIDOSIS; HUMAN; LYSOSOME STORAGE DISEASE; MITOCHONDRIAL RESPIRATION; MULTIPLE SULFATASE DEFICIENCY; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPROTECTION; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; REVIEW; SANFILIPPO SYNDROME; SIGNAL TRANSDUCTION; ANIMAL; DEGENERATIVE DISEASE; METABOLISM; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; HUMANS; LYSOSOMAL STORAGE DISEASES; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NEURODEGENERATIVE DISEASES; REACTIVE OXYGEN SPECIES;

EID: 85018764113     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-017-0048-0     Document Type: Review

References (60)

1. Alavian KN, Beutner G, Lazrove E et al (2014) An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci U S A 111:10580–10585
2. Bahat-Stroomza M, Gilgun-Sherki Y, Offen D et al (2005) A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson’s disease. Eur J Neurosci 21:637–646
3. Bove J, Martinez-Vicente M, Vila M (2011) Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci 12:437–452
4. Cali T, Ottolini D, Negro A, Brini M (2012) Alpha-Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J Biol Chem 287:17914–17929
5. Cantuti Castelvetri L, Givogri MI, Hebert A et al (2013) The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3beta and deregulation of molecular motors. J Neurosci 33:10048–10056
6. Cao Y, Staropoli JF, Biswas S et al (2011) Distinct early molecular responses to mutations causing vLINCL and JNCL presage ATP synthase subunit C accumulation in cerebellar cells. PLoS One 6:e17118
7. Carraro M, Giorgio V, Sileikyte J et al (2014) Channel formation by yeast F-ATP synthase and the role of dimerization in the mitochondrial permeability transition. J Biol Chem 289:15980–15985
8. Chen S, Owens GC, Crossin KL, Edelman DB (2007) Serotonin stimulates mitochondrial transport in hippocampal neurons. Mol Cell Neurosci 36:472–483
9. Dasgupta N, Xu YH, Li R et al (2015) Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. Hum Mol Genet 24:7031–7048
10. Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjorklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A 110:E1817–E1826
11. Eldar-Finkelman H, Martinez A (2011) GSK-3 inhibitors: preclinical and clinical focus on CNS. Front Mol Neurosci 4:32
12. Fernandez A, Llacuna L, Fernandez-Checa JC, Colell A (2009) Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced inflammation and neurotoxicity. J Neurosci 29:6394–6405
13. Fossale E, Wolf P, Espinola JA et al (2004) Membrane trafficking and mitochondrial abnormalities precede subunit c deposition in a cerebellar cell model of juvenile neuronal ceroid lipofuscinosis. BMC Neurosci 5:57
14. Fu R, Wassif CA, Yanjanin NM et al (2013) Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1. Hum Mol Genet 22:3508–3523
15. Futerman AH, Boldin SA, Brann AB, Pelled D, Meivar-Levy I, Zisling R (1999) Regulation of sphingolipid and glycosphingolipid metabolism during neuronal growth and development. Biochem Soc Trans 27:432–437
16. Giorgio V, von Stockum S, Antoniel M et al (2013) Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 110:5887–5892
17. Gorlach A, Bertram K, Hudecova S, Krizanova O (2015) Calcium and ROS: a mutual interplay. Redox Biol 6:260–271
18. Hamacher-Brady A, Brady NR (2016) Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci 73:775–795
19. Haq E, Giri S, Singh I, Singh AK (2003) Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line. J Neurochem 86:1428–1440
20. Hoglinger D, Haberkant P, Aguilera-Romero A et al (2015) Intracellular sphingosine releases calcium from lysosomes. elife 4:e10616
21. Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer’s disease. J Neurochem 104:1433–1439
22. Huang Z, Hou Q, Cheung NS, Li QT (2006) Neuronal cell death caused by inhibition of intracellular cholesterol trafficking is caspase dependent and associated with activation of the mitochondrial apoptosis pathway. J Neurochem 97:280–291
23. Johnson SC, Yanos ME, Kayser EB et al (2013) mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science 342:1524–1528
24. Karatas H, Aktas Y, Gursoy-Ozdemir Y et al (2009) A nanomedicine transports a peptide caspase-3 inhibitor across the blood-brain barrier and provides neuroprotection. J Neurosci 29:13761–13769
25. Kennedy BE, LeBlanc VG, Mailman TM et al (2013) Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick type C1-deficient murine brain. PLoS One 8:e82685
26. Kiselyov K, Muallem S (2008) Mitochondrial Ca2+ homeostasis in lysosomal storage diseases. Cell Calcium 44:103–111
27. Kolikova J, Afzalov R, Surin A, Lehesjoki AE, Khiroug L (2011) Deficient mitochondrial ca(2+) buffering in the Cln8(mnd) mouse model of neuronal ceroid lipofuscinosis. Cell Calcium 50:491–501
28. Liu G, Park SH, Imbesi M et al (2016) Loss of NAD-dependent protein deacetylase Sirtuin-2 alters mitochondrial protein acetylation and dysregulates Mitophagy. Antioxid Redox Signal. doi:10.1089/ars.2016.6662
29. Lloyd-Evans E, Morgan AJ, He X et al (2008) Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 14:1247–1255
30. Lojewski X, Staropoli JF, Biswas-Legrand S et al (2014) Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23:2005–2022
31. Luiro K, Kopra O, Blom T et al (2006) Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments. J Neurosci Res 84:1124–1138
32. Martins C, Hulkova H, Dridi L et al (2015) Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model. Brain 138:336–355
33. Medina DL, Fraldi A, Bouche V et al (2011) Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 21:421–430
34. Medina DL, Di Paola S, Peluso I et al (2015) Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat Cell Biol 17:288–299
35. Nath S, Goodwin J, Engelborghs Y, Pountney DL (2011) Raised calcium promotes alpha-synuclein aggregate formation. Mol Cell Neurosci 46:516–526
36. Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148:1145–1159
37. Okada R, Wu Z, Zhu A et al (2015) Cathepsin D deficiency induces oxidative damage in brain pericytes and impairs the blood-brain barrier. Mol Cell Neurosci 64:51–60
38. Osellame LD, Rahim AA, Hargreaves IP et al (2013) Mitochondria and quality control defects in a mouse model of Gaucher disease--links to Parkinson’s disease. Cell Metab 17:941–953
39. de Pablo-Latorre R, Saide A, Polishhuck EV, Nusco E, Fraldi A, Ballabio A (2012) Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 21:1770–1781
40. Palmieri M, Pal R, Nelvagal HR et al (2017) mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8:14338
41. Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC et al (2011) Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:3242–3258
42. Pickrell AM, Youle RJ (2015) The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson’s disease. Neuron 85:257–273
43. Plotegher N, Duchen MR (2017) Mitochondrial dysfunction and neurodegeneration in lysosomal storage disorders. Trends Mol Med 23:116–134
44. Raffaello A, Mammucari C, Gherardi G, Rizzuto R (2016) Calcium at the Center of Cell Signaling: interplay between endoplasmic reticulum, mitochondria, and lysosomes. Trends Biochem Sci 41:1035–1049
45. Rama Rao KV, Kielian T (2016) Astrocytes and lysosomal storage diseases. Neuroscience 323:195–206
46. Sano R, Annunziata I, Patterson A et al (2009) GM1-ganglioside accumulation at the mitochondria-associated ER membranes links ER stress to ca(2+)-dependent mitochondrial apoptosis. Mol Cell 36:500–511
47. Sanz-Blasco S, Valero RA, Rodriguez-Crespo I, Villalobos C, Nunez L (2008) Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs. PLoS One 3:e2718
48. Sato S, Koike M, Funayama M et al (2016) Lysosomal storage of subunit c of mitochondrial ATP synthase in brain-specific Atp13a2-deficient mice. Am J Pathol 186(12):3074–3082
49. Settembre C, Fraldi A, Jahreiss L et al (2008) A block of autophagy in lysosomal storage disorders. Hum Mol Genet 17:119–129
50. Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson’s disease. N Engl J Med 361:1651–1661
51. Takamura A, Higaki K, Kajimaki K et al (2008) Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis. Biochem Biophys Res Commun 367:616–622
52. Tang BL (2016) Sirt1 and the mitochondria. Mol Cells 39:87–95
53. Torres S, Matias N, Baulies A et al (2016) Mitochondrial GSH replenishment as a potential therapeutic approach for Niemann Pick type C disease. Redox Biol 11:60–72
54. Verity C, Winstone AM, Stellitano L, Will R, Nicoll A (2010) The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child 95:361–364
55. Voccoli V, Tonazzini I, Signore G, Caleo M, Cecchini M (2014) Role of extracellular calcium and mitochondrial oxygen species in psychosine-induced oligodendrocyte cell death. Cell Death Dis 5:e1529
56. Walkley SU (2004) Secondary accumulation of gangliosides in lysosomal storage disorders. Semin Cell Dev Biol 15:433–444
57. Wei H, Zhang Z, Saha A et al (2011) Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol. Hum Mol Genet 20:1111–1121
58. Xu YH, Xu K, Sun Y et al (2014) Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice. Hum Mol Genet 23:3943–3957
59. Yamada T, McGeer PL, Baimbridge KG, McGeer EG (1990) Relative sparing in Parkinson’s disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res 526:303–307
60. Yu W, Gong JS, Ko M, Garver WS, Yanagisawa K, Michikawa M (2005) Altered cholesterol metabolism in Niemann-Pick type C1 mouse brains affects mitochondrial function. J Biol Chem 280:11731–11739